Serum uric acid in systemic lupus erythematosus with preserved renal function: a cross-sectional and longitudinal analysis

• by Xiaolu Huang, Hongpu Chen, Yulin Wang, Fuan Lin

• May 7, 2026

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.

• by Kathryn Wighton

• April 28, 2026

• 2 min

Connective tissue diseases combined with chronic myelomonocytic leukemia and myelofibrosis: a case report and literature review

• by Hai-Qin Yin, Sha Jin, Yao Fu, Hui-Ling Zhu, Xue-Fei Li

• May 14, 2026

Editorial: The role of innate immunity in the pathogenesis of autoimmune and autoinflammatory diseases

• by Carmelo Carmona-Rivera, Diana Gómez-Martín, José Luis Maravillas-Montero, José Jiram Torres-Ruiz

• May 8, 2026